Interventional immunology in neonatal diseases and beyond | Led by A/Prof. Claudia Nold and Prof. Marcel Nold | @Hudson_Research @MonashUni
Melbourne, Australia
Joined October 2015
- Tweets191
- Following271
- Followers364
- Likes465
Nold Laboratory retweeted
BioCurate's Proof of Concept Fund empowers exceptional teams like Prof. Claudia Nold & @dr_ellisdon in their groundbreaking IL-38 research. We're proud to support and accelerate innovative projects that address critical gaps in inflammatory disease treatment. biocurate.com/news/biocurate… #MedicalResearch #DrugDiscovery #Innovation #BioCurate @monashBDI @Hudson_Research
Nold Laboratory retweeted
Important paper highlighting the effect of ANAKINRA in reducing lung injury
Key is timing - the earlier the better
Nold Laboratory retweeted
Now the @NoldLab is assessing the safety of ANAKINRA in extremely preterm infants led by @ellyg16 at @MonashHealth
Full protocol details ncbi.nlm.nih.gov/pmc/article…
Study nearly done - coming soon, stay tuned
Nold Laboratory retweeted
In a study published in @ScienceTM, we had shown that early HBVV was associated with Type 2 immune polarization.
Type 2 immune polarization is associated with cardiopulmonary disease in preterm infants pubmed.ncbi.nlm.nih.gov/3538…
More data on early HBVV & risk of BPD coming soon.
Nold Laboratory retweeted
Do you prescribe the birth dose of Hepatitis B vaccine in preterm infants?
New study in @Vaccines_MDPI confirms the lack of evidence around its safety (esp long term) in preterm infants (esp very preterm). mdpi.com/2076-393X/12/3/261
Why did we study this?
Read below...
Nold Laboratory retweeted
Our latest paper is out today!Congratulations @Sarah_Rosli_
@CiiiD_Hudson @Hudson_Research doi.org/10.1038/s41419-023-0…
Nold Laboratory retweeted
Congrats to A/Prof @Dr_MLHalls, Prof Martin Scanlon, Prof Simon Bell & Dr @Priebbenow_Chem on being awarded @arc_gov_au #DiscoveryProject grants 👏👏
Find out more 👉 monash.edu/pharm/about/news/…
#DP24 @CentMedUseSafet @MIPS_DDB
Nold Laboratory retweeted
Could harnessing the body’s own #ImmuneSystem stop the progression of #OvarianCancer?
Read more about Dr Zoe Marks, Prof Paul Hertzog, Dr Nicole Campbell (L-R) & the team's latest research in the prestigious journal @Nature or here bit.ly/3KJCFzY
Nold Laboratory retweeted
Our latest work on the #microbiome and #ibd looks at 286 patient biopsies with shotgun metagenomics, host transcriptomics and over 6000 cultured isolates to identify site-specific bacterial clades (rather than taxonomy) associated with disease. @Hudson_Research @CiiiD_Hudson
Online now: Bacterial clade-specific analysis identifies distinct epithelial responses in inflammatory bowel disease dlvr.it/SsNGv3
Nold Laboratory retweeted
Using technology A/Prof Ashley Mansell (left) developed, he is working with @AdisoTx to create treatments targeted to #Inflammasomes, with the potential to treat a range of diseases.
Read more in the Journal Clinical & Translational Immunology or bit.ly/3D2fOLO
ALT L-R, A/Prof Ashley Mansell, Research Assistant Callum Docherty
Nold Laboratory retweeted
Elevated levels of CGRP protein are found in the blood and saliva during migraine attacks. @SarahJ_Piper (@PiperProteins) describes this receptor as looking like a flower and “a symbol for the ‘blooming’ drug discovery research”.
#MigraineAwarenessMonth
Nold Laboratory retweeted
Inflammation of vessels and its influence on lung disease: Options beyond steroids. Clinicians & scientists come together to propose a new treatise (Sehgal et al)
@The_BPD_Collab @EricFMorand @Dr_KS_Gautham @physoc @AuPhysiolSoc @rodwhunt @RitchieCentre
#ArticlesinPress: @Arvind_Monash @NoldLabet al. summarize alternative anti-inflammatory treatment options for #BronchopulmonaryDysplasia in premature infants - new in @japplphysiol!
ow.ly/SXkp50OxCte
#Prematurity #Inflammation #Interleukins @Hudson_Research @MonashUni
Nold Laboratory retweeted
Could a newborn’s lung microbiome affect the immune system throughout one's life?
Read Prof Claudia Nold, Prof Marcel Nold, Sara di Simone, A/Prof Sam Forster & Dr Ina Rudloff's (L-R) review in the journal Science Translational Medicine, or read more here bit.ly/3M1TeIe
ALT Prof Claudia Nold, Prof Marcel Nold, Sara di Simone, A/Prof Sam Forster and Dr Ina Rudloff (L-R) at Hudson Institute
Nold Laboratory retweeted
It's been a pleasure to host Professor Marcel Nold @NoldLab at the Liggins Institute @AucklandLiggins
Thank you, Marcel, for your inspiring talk on inflammatory complications of prematurity and the ongoing Anakinra Pilot trial.
Nold Laboratory retweeted
An excellent piece of work from @AsthmaAustralia in identifying the top 10 consumer research priorities in asthma. Important work to drive person centred asthma research and care 🌟
🌏Respirology
Identifying the #asthma research priorities of people with asthma, their carers and other stakeholders- a new research report in #Respirology in Open Access
ow.ly/MYxv50Nmarq
@anthonywflynn; @PeterThorSoc; @AsthmaAustralia
Nold Laboratory retweeted
Check out our new latest review in @ScienceTM on respiratory microbiome-immune system interactions in health and disease @NoldLab and @_sam_forster_. science.org/doi/pdf/10.1126/…
Nold Laboratory retweeted
Baby Max was born at just 27 weeks. #PrematureBaby
When the opportunity arose for Max to be the first participant in a trial of a new treatment, #Anakinra, his mum Susana readily agreed.
Read more or to #Donate to our Infants’ Health Appeal: bit.ly/3DJqOgY
@NoldLab
ALT "We’re very proud that out of such a dark time for our family we also did something good." – Susana, Max's mum
Nold Laboratory retweeted
On the Cover: Murine model for #neonatal #cardiopulmonary disease shows changes in lung morphology after prenatal systemic inflammation and postnatal hyperoxia compared to air controls
📰 Full protocol: bit.ly/3DRK8Zn
By @NoldLab @SCSMonash @Hudson_Research
ALT Emphysematous changes in lung morphology (H&E staining) at 28 days of life after antenatal LPS and postnatal exposure to 65% hyperoxia compared to air controls in C57BL/6J mice (sourced from Rudloff et al., 2017). Scale bars 100 µm, ×200 magnification.